Press Releases April 20, 2026 06:30 AM

BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026

KANZHUN LIMITED advances strong shareholder value through extensive share repurchases in 2026

By Derek Hwang BZ

KANZHUN LIMITED (BOSS Zhipin), a company listed on Nasdaq and Hong Kong stock exchanges, announced April 17th repurchases of 349,698 shares using RMB17.0 million. Year-to-date 2026, the company has invested over RMB913 million in repurchasing shares, reiterating its dedication to enhancing shareholder value.

BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026
BZ

Key Points

  • KANZHUN LIMITED repurchased 349,698 shares on April 17, 2026, using RMB17.0 million.
  • The total amount spent on share repurchases in 2026 has exceeded RMB913 million.
  • The share repurchase program highlights the company's commitment to returning capital to shareholders.

BEIJING, April 20, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing over RMB17.0 million to repurchase 349,698 ordinary shares on April 17. Year-to-date in 2026, the Company has deployed over RMB913 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns.


Risks

  • Continued large-scale share repurchases may limit available capital for operational growth or strategic investments.
  • Market conditions or regulatory changes could impact future buyback activities.
  • Overemphasis on buybacks might mask underlying business performance challenges.

More from Press Releases

Northrop Grumman Board Declares Quarterly Dividend May 19, 2026 NOVAGOLD Announces Election of Directors and Voting Results from 2026 Virtual Annual General Meeting of Shareholders May 19, 2026 Diana Shipping Inc. Releases Investor Presentation Highlighting Need for Change at Genco Shipping & Trading May 19, 2026 Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 19, 2026 Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference May 19, 2026